1 The mechanisms of the antiproliferative eect of epigallocatechin, one of the catechin derivatives found in green tea, in vascular smooth muscle cells were studied. The proliferative response was determined from the uptake of tritiated thymidine. 2 In the concentration range of 10 76 to 10 74 M, catechin, epicatechin, epigallocatechin, epicatechin gallate and epigallocatechin, epigallocatechin gallate, concentration-dependently inhibited the proliferative response stimulated by serum in rabbit cultured vascular smooth muscle cells. Catechin and epicatechin were less eective in inhibiting the serum-stimulated smooth muscle cell proliferation, indicating that the galloyl group may be important for full inhibitory activity.
Introduction
Atherosclerosis and post-angioplasty restenosis are characterized by the abnormal accumulation of vascular smooth muscle cells, in¯ammatory cells and extracellular matrix proteins (Lundergan et al., 1991; Ross, 1993) . The proliferative responses of both vascular smooth muscle cells (SMC) and mononuclear cells are important in the pathogenesis of atherosclerosis and restenosis. We have previously found that some plant polyphenols reduced the proliferative responses of vascular SMC (Huang et al., 1992a,b; 1993; 1994a,b) . Recently, we found that tea catechins reduced the proliferative responses of vascular SMC and human lymphoblastoid leukaemia (CEM) lymphocytes. Tea is traditionally and widely consumed as a beverage in the Orient. Green tea leaves contain a large amount (30% dry weight) of catechins (Graham, 1992) . These catechins have many phenolic hydroxyl groups in their structures and are often called tea polyphenols. The term green tea refers to the product manufactured from fresh leaves while preventing oxidation of the polyphenolic components. Catechins contained in green tea consist mainly of epicatechin, epigallocatechin (EGC), epicatechin gallate and epigallocatechin gallate (Graham, 1992) . These catechins have been shown to exert pharmacological eects including antioxidative, hypolipidaemic, antihypertensive and antimutagenic eects (Ikeda et al., 1992) . Many laboratory studies have demonstrated inhibitory eects of tea preparations and tea polyphenols on tumour formation and growth. This inhibitory activity is believed to be mainly due to the antioxidative and possible antiproliferative eects of polyphenolic compounds in green tea (Yang & Wang, 1993) . In the present study, the possible mechanisms of action of the antiproliferative eect of EGC were investigated. We have previously shown that esculetin, a plant phenol, inhibits protein tyrosine kinase activity, thereby reducing the proliferative response of vascular smooth muscle cells (Huang et al., 1993) . Therefore, it seemed of interest to investigate the eect of catechins on signal transduction pathways. The induction of c-fos, c-jun, and cmyc protoonocogenes expression, one of the earliest events associated with growth factor stimulation, can be detected in rat aortic smooth muscle cells following endothelial removal (Miano et al., 1990) . In this study, the molecular mechanisms of the antiproliferative eect of EGC were investigated to determine whether the transduction signals and protooncogenes expression were aected.
Methods

Measurement of cell proliferation
A7r5 cells (rat aortic smooth muscle cells) and rabbit cultured vascular smooth muscle cells (rabbit VSMC) were grown in Dulbecco's modi®ed Eagle's medium (supplemented with 10% v/v foetal calf serum, 100 u ml 71 penicillin, and 10 76 g ml 71 streptomycin). Human coronary artery smooth muscle cells (human CASMC) were grown in medium containing SmBM (Clonetics Corporation's BulletKit containing growth factors and antimicrobials). The proliferative responses of A7r5 cells, rabbit cultured VSMC, and human CASMC were determined by the uptake of tritiated thymidine (Huang et al., 1992b) . Before all the experiments, con¯uent smooth muscle cells were rendered quiescent by culturing for 48 h (with one medium change after 24 h) in 0.5% v/v foetal calf serum (FCS) instead of 10%. In rabbit VSMC (2.5610 4 cells/well) and human CASMC (2.5610 4 cells/well), 5% v/v FCS together with the test compound were then added to the medium 24 h before [ 3 H]-thymidine (0.2 mCi/well) was included in the medium. Twenty-four hours after the addition of [ 3 H]-thymidine, the cells were harvested and the amount of [ 3 H]-thymidine incorporated into DNA was counted in a liquid scintillation counter. In A7r5 cells (10 4 cells/well), 5% v/v FCS and the test compound were added to the medium 16 h before [ 3 H]-thymidine (1 mCi/well) was included in the medium. Four hours after addition of [ 3 H]-thymidine, the cells were harvested and the [ 3 H]-thymidine incorporated was counted. CEM cells (human CEM lymphocytes) were cultured in RPMI-1640 medium containing 10% v/v FCS. Assessment of CEM cells proliferation was performed by [ 3 H]-thymidine incorporation assay as described previously (Watabe et al., 1984; Huang et al., 1994a) . The test compound was added to the CEM cells suspension (5610 3 cells/well) in the presence of 10% v/v FCS. Reaction mixtures were incubated in a CO 2 incubator at 378C for 0.5 h before 1 mCi [ 3 H]-thymidine was added to each well. After an additional 4 h of incubation, cells were harvested and the [ 3 H]-thymidine incorporated to cells was counted.
Each experiment was performed in triplicate and repeated 5 or 6 times. The inhibitory activity of the test compound is expressed as percentage of the untreated control value. The concentration evoking 50% maximal inhibition (IC 50 ) was calculated for each experiment.
Cell viability was determined with the trypan blue dye exclusion method. After addition of the test compound for 20 h, cells were harvested from the dishes using a 0.1% w/v trypsin solution, and the viability was examined by the trypan blue dye exclusion test. The number of viable cells was estimated by microscopic cell counting using a haemocytometer.
Measurement of protein tyrosine kinase activity
The membranous protein tyrosine kinase activity of A7r5 cells was measured as previously described (Huang et al., 1993) . A7r5 cells were lysed in ice-cold extraction buer, containing 10 mM Tris-HCl (pH 7.4), 1 mM MgCl 2 , 1 mM EDTA, 250 mM sucrose, 1 mM dithiothreitol, 50 kiu aprotinin and 1 mM phenylmethylsulphonyl¯uoride, by a sonicator. The suspension was centrifuged ®rst at 800 g for 10 min and then at 100,000 g for 1 h. The ®nal pellet was resuspended in solubilizing buer containing 50 mM Tris-HCl (pH 7.5), 20 mM Mg(C 2 H 3 O 2 ) 2 5 mM NaF, 0.2 mM EDTA, 0.8 mM EGTA, 1 mM dithiothreitol, and 30 mM Na 3 VO 4 , and resonicated. After a 1 h incubation on ice, the homogenate was centrifuged at 100,000 g for 1 h. The supernatant thus obtained was the membrane fraction. The protein tyrosine kinase activity in the resultant supernatant was assayed with a protein tyrosine kinase assay kit (Gibco) by incubating with the synthetic peptide substrate, RR-SRC (Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-Tyr-Ala-Ala-Arg-Gly), in the presence of [g-32 P]-ATP, and activating enzyme with 5% v/v FCS. After removal of protein by acid precipitation, labelled peptide was bound to a phosphocellulose disc and phosphorylation of the peptide was measured by a scintillation counter. The protein content was determined according to the method of Lowry et al. (1951) . The results are expressed as pmol 32 P incorporated mg 71 protein min 71 .
Measurement of protein kinase C activity
The protein kinase C activity of A7r5 cells was measured as previously described (Huang et al., 1993) . A7r5 cells were lysed in ice-cold buer A containing 20 mM Tris-HCl (pH 7.5), 2 mM EDTA, 0.5 mM EGTA, 300 mM sucrose, 2 mM phenylmethylsulphonyl¯uoride and 23 mM leupeptin by a sonicator. After centrifugation at 2,500 g for 5 min, the supernatant was centrifuged at 100,000 g for 1 h, and the resulting supernatant was retained as the cytosol fraction. After ultracentrifugation, the pellets were washed with buer B (buer A without sucrose) by centrifugation (12,000 g, 15 min), resuspended in buer B with 1% v/v Triton X-100, and resonicated. After a 1 h incubation at 48C, the homogenate was centrifuged at 100,000 g for 1 h, and the supernatant thus obtained was the membrane fraction. Protein kinase C activity was measured using a protein kinase C assay kit (Amersham) by a modi®cation of a mixed micelle assay (Hannun et al., 1985) , activating the enzyme with 39 mM phorbol-12-myristate-13-acetate. After removal of protein by acid precipitation, labelled peptide was bound to a phosphocellulose disc and phosphorylation of the peptide was measured by scintillation counter. The protein content was determined according to the method of Lowry et al. (1951) . The results are expressed as pmol 32 P incorporated mg 71 protein min 71 .
RT-PCR analysis of c-fos, c-jun and c-myc mRNA expression
The expression of c-fos, c-jun and c-myc mRNA was analysed by the reverse transcription-polymerase chain reaction (RT-PCR) technique (Wang et al., 1989; Huang et al., 1994a) . Before the RNA extraction, con¯uent smooth muscle cells were rendered quiescent by culturing for 48 h in 0.5% v/v FCS instead of 10%. Then, test compound together with 5% v/v FCS were added to the medium and incubated for the indicated time period. Total cellular RNA was prepared by acid guanidinium thiocyanate extraction (Chomczynski & Sacchi, 1987) . And, RNA was then reverse transcribed into cDNA. A 20 ml reverse transcription reaction mixture containing 1 mg of total cellular RNA, 16PCR buer (10 M Tris-HCl, pH 8.3, 50 mM KCl), 0.3 mM deoxynucleoside triphosphates (dNTPs), 1 unit of RNase inhibitor, 2.5 mM of oligo(dT) 16 , and 10 units of M-MLV reverse transcriptase was incubated at 428C for 1 h, heated to 958C for 5 min, and then quick-chilled at 58C for for 5 min, PCR was performed at a ®nal concentration of 16PCR buer/0.5 mM each 3' and 5' primers/2.5 unit of AmpliTaq DNA polymerase (Perkin-Elmer) in a total volume of 100 ml. The mixture was ampli®ed for 35 cycles with the Perkin-Elmer thermal cycler (GeneAmp PCR System 9600). The ampli®cation pro®le involved denaturation at 958C for 15 s, annealing and extension at 658C for 15 s. Primers for c-fos, c-jun and c-myc (Clontech) were used to generate 612, 409, and 479 bp fragments, respectively. The GAPDH primer (452 bp) was used as the internal standard. In each experiment, the negative control without reverse transcriptase was performed. Ampli®cation products were separated by agarose gel electrophoresis and visualized by ethidium bromide staining. The gel was photographed with Polaroid type 667 ®lm, and the digitized images were analysed by an image analyser (Winstar LV1, Taiwan). The protooncogenes signal intensity was normalized to its respective GAPDH signal intensity and expressed in arbitrary units. Samples were further con®rmed by Southern blotting using standard methods (Sambrook et al., 1989) .
In a preliminary experiment, various aliquots taken from the RT reaction were used in PCR for analysis of the test transcripts. The amounts of cDNA produced were proportional to the inputs of the RT-PCR products in the range 0.5 to 5 ml. Therefore, in subsequent experiments, the amounts of reverse-transcriptase products taken for PCR ampli®cation of the test transcripts were within the linear ranges, in order to ensure that the amounts of cDNA produced truly re¯ect the levels of mRNA in the original samples.
Western blot analysis
Before the experiments, con¯uent smooth muscle cells were rendered quiescent by culturing for 48 h in 0.5% v/v FCS instead of 10%. The cells were then treated with stimulator (serum or tumour necrosis factor-a (TNF-a)) and test compound. At the end of the various treatments, cells were lysed in lysis buer (1% Triton X-100, 20 mM HEPES pH 7.4, 50 mM b-glycerophosphate, 10% glycerol, 2 mM EGTA, 1 mM dithiothreitol, 10 mM sodium¯uoride, 1 mM sodium orthovanadate, 2 mM leupeptin, 2 mM aprotinin, 1 mM phenylmethyl-sulphonyl¯uoride) for 4 min on ice. Soluble extracts were prepared by centrifugation at 16,000 g for 10 min at 48C. An equal volume of 26 sampling buer (0.25 M Tris, pH 6.8, 4 mM EDTA disodium, 4% SDS, 20% glycerol, 10% 2mercaptoethanol and 0.004% bromophenol blue) was added, and the cell extract was boiled for 4 min. Samples were separated by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) using 12% gradient polyacrylamide gel. After electrophoresis, proteins were electrotransferred to a polyvinylidene di¯uoride membrane. Nonspeci®c binding sites on the membrane were blocked by incubation with 3% BSA in TBST buer (20 mM Tris, pH 7.4, 150 mM sodium chloride, 1 mM EDTA, 1 mM sodium orthovanadate, 0.05% Tween-20) for 90 min at room temperature. For Western blot assay of the levels of tyrosine phophorylated proteins, the membrane was then incubated with antiphosphotyrosine monoclonal antibody (PY-20, 1:1000 dilution) at 48C for overnight at rotating table. After 10 min washes, the membrane was incubated with secondary antibody (goat antimouse IgG antibody, alkaline phosphatase conjugated) for 2 h at room temperature. The speci®c bands were visualized with the NBT/BCIP substrate of alkaline phosphatase.
For Western blot analysis of expression and phosphorylation of JNK or ERK, antibodies against JNK1 (46-kDa), ERK1 (44-kDa) and ERK2 (42-kDa) were used instead of PY-20. The signal intensity was quanti®ed by an image analyser (Winstar LV1, Taiwan) and expressed in arbitrary units as a fold increase of the signal obtained with untreated cells.
Immunoprecipitation and kinase activity assays of JNK1
Quiescent A7r5 cells were treated with stimulator (serum or TNF-a) and test compound, and then lysed in lysis buer. Soluble extracts were prepared by centrifugation at 16,000 g for 10 min at 48C. Following normalization of protein content, endogenous c-Jun N-terminal kinase-1 (JNK1) was immunoprecipitated from the cell extracts using rabbit polyclonal antibodies against JNK1 and protein A-agarose. Kinase activity was then assayed for 20 min at 308C in the presence of 6 mg substrate, 30 mM ATP, and 20 mCi of [g-32 P]-ATP in 55 ml assay buer (20 mM MOPS, pH 7.2, 2 mM EGTA, 20 mM MgCl 2 0.1% Triton X-100, 1 mM dithiothreitol). GSTc-Jun (1 ± 169) was used as a substrate for JNK1 activity. After completion of kinase activity assay, the protein was resolved by SDS-polyacrylamide gel electrophoresis, and the gels were dried and subjected to autoradiography. The incorporation of 32 P was quanti®ed using a densitometer and expressed in arbitrary units as a fold increase of the signal obtained with untreated cells.
Materials
(+)-Catechin, (7)-epicatechin, (7)-epigallocatechin, (7)epicatechin gallate and (7)-epigallocatechin gallate were purchased from Kurita Co. (Tokyo, Japan) ( Figure 1 ). Rat aortic smooth muscle cells (A7r5 cells) and human CEM lymphocytes (CEM cells; human lymphoblastoid leukaemia cells) were purchased from the American Type Culture Collection (Rockville, MD). Human coronary artery smooth muscle cells (human CASMC) and SmBM smooth muscle growth medium (BulletKit containing growth factors and antimicrobials) were purchased from Clonetics Corporation (San Diego, CA). Rabbit cultured smooth muscle cells were isolated from rabbit thoracic aorta and cultured as previously described (Huang et al., 1992b) . Foetal calf serum, penicillin, streptomycin, Dulbecco's modi®ed Eagle's medium (DMEM), RPMI-1640 medium, and goat anti-mouse IgG antibody (alkaline phosphatase conjugated) were purchased from Gibco Life Technologies (Grand Island, NY). Thymidine [methyl-3 H] (5 Ci mmol 71 ) and [g-32 P]-ATP (5000 Ci mmol 71 ) were purchased from Amersham Co. (Buckinghamshire, U.K.). Aprotinin, leupeptin, phenylmethylsulphonyl¯uoride, dithiothreitol, genistein (4',5,7-trihydroxy-iso¯avone), H-7 (1-(5isoquinoline-sulphonyl)-2-methyl-piperazine 2HCl), Tris (tris [hydroxymethyl] aminomethane, HEPES hydroxyethylpiperazine-N'-2-ethanesulphonic acid), propanesulphonic acid) and nitro blue tetrazolium/5-bromo-4chloro-3-indolyl phosphate (NBT/BCIP, substrate of alkaline phosphatase) were purchased from Sigma Chemical Co. (St. Louis, MO). Antiphosphotyrosine monoclonal antibody (PY 20), antibody against ERK1 or ERK2, and protein A-agarose were purchased from Transduction Lab., Inc. (Lexington, KY). Antibodies against JNK1 was purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Glutathione-Stransferase fusion protein of c-Jun (1 ± 169)(GST-c-Jun) was purchased from Upstate Biotechnology, Inc. (Lake Placid, NY). PVDF-PLUS transfer membrane (polyvinylidene diuoride) was purchased from Micron Separations, Inc., (Westborough, MA). Moloney murine leukaemia virus (M-MLV) reverse transcriptase and AmpliTaq DNA polymerase were purchased from Perkin-Elmer (Norwalk, CT). Primers for c-fos (612 bp), c-jun (409 bp), c-myc (479 bp), and GAPDH (452 bp) for PCR were purchased from Clontech Lab., Inc. (Palo Alto, CA).
Statistical analysis
The data are expressed as mean+s.e.mean. P values less than 0.05 were considered to be statistically signi®cant (ANOVA and Student's t test).
Results
Antiproliferative eects
Cell proliferation was studied by measuring the incorporation of [ 3 H]-thymidine into DNA in dierent cell types. The control values of [ 3 H]-thymidine incorporation in A7r5 cells (10 4 cells/ well), rabbit vascular smooth muscle cells (2.5610 4 cells/well), human coronary artery smooth muscle cells (2.5610 4 cells/ well), and human CEM lymphocytes (5610 3 cells/well) stimulated by FCS without test compound were 7266 +755, 12,283+879, 3250+837, and 7031+322 c.p.m./well, respectively. The eects of catechin, epicatechin, epigallocatechin, epicatechin gallate and epigallocatechin gallate on the serumstimulated proliferative response of vascular smooth muscle cells were studied (Table 1) . Exposure of rabbit cultured vascular smooth muscle cells to all catechin derivatives in the concentration range of 10 76 to 10 74 M, signi®cantly inhibited the [ 3 H]-thymidine incorporation in a concentration-dependent manner. The inhibitory activities of catechins are shown in Table 1 (n=5). Catechin and epicatechin were less eective inhibitors than epigallocatechin, epicatechin gallate and epigallocatechin gallate.
Exposure of dierent cell types to epigallocatechin (EGC) inhibited serum-stimulated proliferation in a concentrationdependent manner. The IC 50 and maximal suppression values of EGC in various cell types are shown in Table dependently inhibited the proliferative responses of A7r5 and CEM cells (n=5). Cell viability, as determined by the trypan blue dye exclusion method, was not aected by optimal concentrations of EGC (510 73 M) (Figure 3 ) (n=5). The numbers of viable cells after EGC treatment (10 77 ± 10 74 M) were more than the basal value (10 5 cells).
Eect on protein tyrosine kinase activity
The membranous protein tyrosine kinase activity in serumstimulated A7r5 cells was 3.2+0.2 pmol mg 71 protein min 71 over the basal activity (n=20) (the basal activity of the membranous protein tyrosine kinase without serum-stimulation was 1.15+0.06 pmol mg 71 protein min 71 ). The serumstimulated protein tyrosine kinase activity was signi®cantly reduced by 10 75 M EGC (19.3+2.1% inhibition, n=5) ( Figure  4 ). However, EGC at 10 74 M did not signi®cantly alter the enzyme activity. At a higher concentration, EGC may exert other eects to counteract the inhibitory activity. In our assay system, 10 75 M genistein, a protein tyrosine kinase inhibitor, inhibited protein tyrosine kinase activity by 31.3+4.6% (n=5). The levels of tyrosine phosphorylated proteins were also analysed by Western blot assay using the anti-phosphotyrosine monoclonal antibody PY-20. Quiescent A7r5 cells were stimulated by 5% v/v FCS for dierent time periods (0.5 and 1 h) to activate the protein tyrosine kinase. After immunoblotting with PY20, the phosphorylation of several proteins with dierent molecular weights was observed at both 0.5 and 1 h ( Figure 5, lanes 2 and 4) . EGC (10 75 M) reduced the levels of tyrosine phosphorylated proteins of at least two proteins of molecular weight 220 and 97 kDa ( Figure 5, lanes 3 and 5) . Genistein (10 75 M) also inhibited the tyrosine phosphorylation of proteins ( Figure 5, lanes 6 and 7) . Similar observations were obtained in ®ve independent experiments.
Eect on protein kinase C activity
The cytosolic protein kinase C activity of A7r5 cells was 22.0+1.4 pmol mg 71 protein min 71 (n=16) in the presence of 39 mM phorbol-12-myristate-13-acetate. The protein kinase C activity was unaected by directly incubating with EGC (10 76 ± 10 74 M) ( Figure 6 ) (n=5). In our assay system, 10 75 M H-7, a protein kinase C inhibitor, inhibited protein kinase C activity by 25.2+1.5% (n=5).
Eects on c-fos, c-jun and c-myc mRNA expression
The mRNA levels of three protooncogenes, c-fos, c-jun and cmyc in serum-stimulated A7r5 cells untreated and treated with EGC were measured using the RT-PCR technique. The quiescent A7r5 cells responded to serum-stimulation by markedly increasing c-fos, c-jun and c-myc mRNA levels over their respective basal levels within 0.5 h. The signal intensities of protooncogenes and GAPDH were quanti®ed by an image analyser, and changes in the signal intensities of test genes relative to GAPDH are shown (Figure 7 and bottom of Figure  8a ,b,c). In Figure 7 , a semi-quantitative analysis of c-fos, c-jun, and c-myc mRNA at dierent time points (0.5, 1 and 2 h) after serum-stimulation is shown. The mean expressions of all three mRNAs at 1 h 2 h were less than those at 0.5 h (Figure 7) (n=7). The eects of EGC (10 75 M) on the levels of c-fos, c-jun and c-myc mRNA are shown in Figure 8 . The levels of c-fos and c-myc mRNA were not signi®cantly aected by EGC (Figure 8a ,c) (n=6). However, EGC signi®cantly reduced the serum-stimulated expression of c-jun mRNA by 39.5+7.8 and 29.5+11.9% at 1 and 2 h, respectively (Figure 8b ) (n=6).
Eects on expression and phosphorylation of JNK and ERK
For Western blot analysis of expression and phosphorylation of JNK (c-Jun N-terminal kinase) or ERK (extracellular signal-regulated kinase), antibodies against JNK1 (46 kDa), ERK1 (44 kDa) and ERK2 (42 kDa) were used. Concomitant with the phosphorylation, a shift of the protein band occurred. As shown in Figure 9a and Figure 10 , the unphosphorylated enzyme is apparent as the faster migrating band. Phosphorylation induces a mobility shift resulting in a slower migrating band. In a preliminary experiment, tumour necrosis factor-a (TNF-a, 10 79 M) induced more expression and phosphorylation of JNK1 than did FCS (5% v/v) in A7r5 cells. As shown in Figure 9 , the increases in levels of both unphosphorylated and phosphorylated JNK1 were measurable 0.5 and 1 h after stimulation by 10 79 M TNF-a (Figure 9a, lanes 2 and 4) . EGC (10 75 M) treatment signi®cantly reduced the phosphorylated JNK1 levels 0.5 and 1 h after TNF-a-stimulation (Figure 9a , lanes 3 and 5) (n=5). The changes in unphosphorylated JNK1 did not achieve signi®cance (n=5).
On the other hand, the ERK1 and ERK2 were basally expressed and the expression and phosphorylation of both ERK1 and ERK2 were increased 0.5 and 1 h after serumstimulation ( Figure 10, lanes 2 and 4) . However, the levels of the serum-stimulated ERK phosphorylation were not sig- ni®cantly aected by 10 75 M EGC (Figure 10, lanes 3 and 5) (n=5). These ®ndings suggest that EGC preferentially suppresses signalling events in A7r5 cells leading to phosphorylation of JNK, rather than the ERK system.
Kinase activity assay of JNK1
Anti-JNK1 antibody was used for kinase immunoprecipitation from the soluble fraction of cell lysates. Kinase activity was then assessed by immune complex kinase assay using GST-c-Jun as a substrate. The JNK1 activity of A7r5 cells was markedly increased 0.5 h after TNT-a stimulation (Figure 9b , lane 2). EGC (10 75 M) treatment signi®cantly inhibited TNF-a stimulated JNK activation (Figure 9b, lane 3) (n=5).
Discussion
The present results demonstrate for the ®rst time that tea catechins concentration-dependently inhibited the proliferation of CEM lymphocytes and various vascular smooth muscle cells, including rat aortic smooth muscle cells (A7r5), rabbit cultured aortic smooth muscle cells, and human coronary artery smooth muscle cells. Among the catechin derivatives tested, catechin and epicatechin were less eective in inhibiting the serum-stimulated cell proliferation than epigallocatechin, epicatechin gallate and epigallocatechin gallate, indicating that the galloyl group seems to be important for full inhibitory activity. Tea catechins have been shown to exhibit hypolipidaemic and antioxidant eects. Matsuda et al. (1986) demonstrated that tea catechins were eective in reducing the serum cholesterol level. Ikeda et al. (1992) further showed that tea catechins reduced cholesterol absorption from intestine. On the other hand, catechins have been shown to inhibit low density lipoprotein (LDL) oxidation and the subsequent degradation of the oxidized-LDL by human monocyte-derived macrophages (Mangiapane et al., 1992) . In the present study, tea catechins were eective inhibitors of serum-stimulated mitogenesis in vascular smooth muscle cells and CEM lymphocytes. Atherosclerosis and post-angioplasty restenosis are characterized by the abnormal accumulation of vascular smooth muscle cells, in¯ammatory cells, and extracellular matrix proteins (Lundergan et al., 1991; Ross, 1993) . Thus, tea catechins may be useful in the study and treatment of atherosclerosis and post-angioplasty restenosis. Although there are limited studies on the bioavailability of the polyphenols, the absorption of catechins in man has been shown (Rice-Evans, 1995) . Epidemiological studies, though inconclusive, suggest a protective eect of tea consumption on human cancer and coronary heart disease (Stoner & 1995; Thelle, 1995) . The present results suggest that green tea available in everyday life may be a practical chemopreventive agent for proliferative diseases, such as cancer, atherosclerosis and restenosis. Tea catechins, which possess hypolipidaemic and antiproliferative activities, may be useful as a template for the development of drugs to prevent the pathological changes of atherosclerosis and restenosis. Cell viability assay veri®ed that the eects of EGC were not due to general cellular toxicity. Our results show that EGC may inhibit the proliferative responses through inhibition of transduction signals leading to DNA synthesis. There are some signalling pathways for growth factors and mitogens (Powis & Kozikowski, 1991) . The receptors for growth factors such as platelet-derived growth factor and epidermal growth factor are protein tyrosine kinases. Tyrosine kinase activity has also been found to be associated with other growth factors and oncoproteins (Bishop, 1983) . On the other hand, peptides such as vasopressin and bombesin partly act through cell surface receptors, coupled to a guanine nucleotide binding protein to activate a speci®c phospholipase C that hydrolyzes phosphatidylinositol-4, 5-bisphosphate to inositol-1,4,5-trisphosphate and diacylglycerol. Diacylglycerol then activates protein kinase C (Powis & Kozikowski, 1991) . In the present study, EGC reduced protein tyrosine kinase activity. The inhibitory eect of EGC on tyrosine kinase activity was demonstrated by biochemical method. We also performed Western blot analysis using the anti-phosphotyrosine monoclonal antibody PY-20. EGC reduced the levels of tyrosine phosphorylated proteins, indicating that EGC may inhibit the protein tyrosine kinase activity or stimulate the protein phosphatase activity.
We also examined the eects of EGC on the expression of proto-oncogenes mRNA. The induction of c-fos, c-jun and cmyc mRNA is one of the earliest transcriptional events associated with growth factor stimulation. The products of these oncogenes appear to function as transcriptional regulatory proteins which are involved in the G 1 phase of the cell cycle (Reed et al., 1986; Pardee, 1989) . Our results demonstrate that the reduction of DNA synthesis in vascular smooth muscle cells by EGC is associated with alteration of cjun mRNA expression. Reduction in serum-stimulated protooncogene expression may partly be involved in the antiproliferative eect of EGC. EGC preferentially reduced c-jun, but had less aect on c-fos or c-myc, mRNA levels in the present results, indicating that EGC may preferentially reduce the activation of the JNK/SAPK (c-Jun N-terminal kinase/ stress-activated protein kinase) signal transduction pathway. SAPKs de®ne a stress-activated signalling pathway which regulates the activity of c-Jun (Kyriakis et al., 1994) . The SAPKs are activated in response to cellular stresses, including ischaemia, u.v. light, heat shock, and to in¯ammatory cytokines (Kyriakis et al., 1994; Knight & Buxton, 1996) . The c-Jun protein can be activated by JNK/SAPK or by an increase in transcription of the c-jun gene (Angel et al., 1988; Kyriakis et al., 1994) . Mammalian MAP kinase (mitogenactivated protein kinases) singalling pathways leading to activation of the MAP kinases, ERK, JNK, and p38 have been identi®ed (Davis, 1994; Waskiewicz & Cooper, 1995; Whitmarsh & Davis, 1996) . These are the MAP kinase itself, which is activated by phosphorylation on Thr and Tyr by a dual-speci®city MAP kinase kinase (MAPKK), which in turn is activated by Ser/Thr phosphorylation by a MAP kinase kinase kinase (MAPKKK) (Davis, 1994; Waskiewicz & Cooper, 1995; Whitmarsh & Davis, 1996) . And, MAP kinase can be inactivated by a unique family of dual speci®city phosphatases, MAP kinase phosphatases (MKPs) (Hirsch & Stork, 1997) . By using Western blot analysis of phosphorylated kinase and immune complex kinase activity assay, we further demonstrated that EGC reduced the phosphorylation and kinase activity of JNK1. The JNK have been shown to participate in cellular proliferation via transcriptional activation Kallunki et al., 1994) . The activation of JNK, which phosphorylates the c-Jun activation domain, results in enhanced transcription of AP-1-dependent genes. Therefore, a reduction in JNK activity may partly contribute to the antiproliferative eect of EGC. On the other hand, it has been found that the ERK pathway prolongs survival, whereas activation of the JNK pathway promotes cell death (Xia et al., 1995) . And, sightings of apoptosis have been obtained from every corner of cardiovascular medicine, ranging from restenosis to conduction system defects in congestive heart failure (Yeh, 1997) . EGC could also be ERK 1 ERK 2 Figure 10 Eect of epigallocatechin on ERK expression and phosphorylation in A7r5 cells. Quiescent. A7r5 cells were stimulated by serum in the absence and presence of test compound for the indicated time periods. The levels of unphosphorylated and phosphorylated kinase were analysed by Western blotting using anti-ERK antibody as indicated in Methods. The signal intensities were quanti®ed and changes in protein levels relative to untreated basal levels as shown (bottom) (n=5). Lane 1, cells in the basal condition; lane 2, serum-stimulated control at 0.5 h; lane 3, 10 75 M EGC-treated and serum-stimulated at 0.5 h; lane 4, serum-stimulated control at 1 h; lane 5, 10 75 M EGC-treated and serum-stimulated at 1 h. developed to form a novel therapy for apoptosis. It has been shown that green tea catechins bind to various hepatic cytochrome P450 and inhibit P450-dependent functions (Wang et al., 1988 ). An examination of the structure-activity relationship of catechins demonstrated that the inhibitory eect on the microsomal enzyme system may be due to the galloyl groups or hydroxyl groups on the molecule. Tea catechins has also been reported to block the interaction of tumour promoters, hormones and growth factors with their receptors (Komori et al., 1993) . Studies to elucidate further the structure-activity relationship of the inhibitory eect of EGC on JNK activity are in progress in our laboratory.
In summary, we found that tea catechins exhibited an antiproliferative eect in vascular smooth muscle cells and CEM lymphocytes. The antiproliferative eect of epigalloca-techin in vascular smooth muscle cells may partly be mediated through inhibition of protein tyrosine kinase activity, reduction in c-jun mRNA expression, and inhibition of JNK1 activation. Tea catechins which possess antiproliferative as well as hypolipidaemic activities, may be useful as a template for the development of drugs to prevent the pathological changes of atherosclerosis and post-angioplasty restenosis. For treatment of atherosclerosis and restenosis, the dose range of antiproliferative agent which can slow down the overdrive response of cell division without deleterious eect on the stability of atherosclerosis plaques should be used. This investigation was supported by grants from the National Science Council and Department of Health, Taiwan.
